PMID- 32732929 OWN - NLM STAT- MEDLINE DCOM- 20211025 LR - 20230210 IS - 1530-0285 (Electronic) IS - 0893-3952 (Linking) VI - 34 IP - 1 DP - 2021 Jan TI - A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors. PG - 42-50 LID - 10.1038/s41379-020-0636-7 [doi] AB - Krukenberg tumor (KT) refers to a rare ovarian tumor that has metastasized from a primary site. Patients with KTs have a poorer prognosis and worse survival. Thus far, little is known about the frequency of receptor tyrosine kinase (RTK) gene amplification and the concordance of gene amplification between primary tumors, lymph-node metastases, and KTs. Herein, 50 paired samples, including primary cancers, metastatic lymph nodes, and KTs were collected, and RTK gene amplification was tested by fluorescence in situ hybridization (FISH). There were four cases positive for human epidermal growth factor receptor type 2 (HER2) amplification, all of which showed conversion of HER2 status between different lesions. Of the two cases with c-mesenchymal-epithelial transition (c-MET) amplification, the primary tumors and lymph nodes were negative while the right involved ovaries were positive. Inconsistent fibroblast growth factor receptor 2 (FGFR2) status in different lesions was observed in three of the six FGFR2-amplified cases. Co-amplification of RTK genes was identified in only one patient for primary cancer and two for KTs. Collectively, there were 46, 48, 50, and 44 cases negative for HER2, c-MET, EGFR, and FGFR2 amplification in all lesions, respectively. There was no significant difference in overall survival between KTs of gastric origin and colorectal origin. However, of all synchronous cancers, KTs of colorectal origin had a better prognosis than those of gastric origin. In conclusion, the positive rate of RTK gene amplification in KTs was low. Intratumoral heterogeneity was frequent in KTs with RTK gene amplification. A mutually exclusive pattern of RTK gene amplification was dominant in primary cancers, lymph-node metastases, and KTs. There was no survival difference between KTs of gastric origin and colorectal origin. However, of all synchronous cancers, KTs of colorectal origin had a better prognosis than those of gastric origin. FAU - Wang, Bo AU - Wang B AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. FAU - Tang, Qiusu AU - Tang Q AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. AD - Department of Pathology and Pathophysiology, College of Medicine, Zhejiang University, 310058, Hangzhou, Zhejiang Province, China. FAU - Xu, Liming AU - Xu L AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. AD - Department of Pathology and Pathophysiology, College of Medicine, Zhejiang University, 310058, Hangzhou, Zhejiang Province, China. FAU - Teng, Xiaodong AU - Teng X AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. FAU - Ding, Wei AU - Ding W AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. FAU - Ren, Guoping AU - Ren G AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. wanglingjane@163.com. AD - Department of Pathology and Pathophysiology, College of Medicine, Zhejiang University, 310058, Hangzhou, Zhejiang Province, China. wanglingjane@163.com. FAU - Wang, Xiaoling AU - Wang X AD - Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003, Hangzhou, Zhejiang Province, China. 1307025@zju.edu.cn. LA - eng PT - Comparative Study PT - Journal Article DEP - 20200730 PL - United States TA - Mod Pathol JT - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc JID - 8806605 RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) SB - IM MH - Adult MH - Aged MH - Colorectal Neoplasms/*genetics/secondary MH - Female MH - Gene Amplification MH - Humans MH - Krukenberg Tumor/*genetics MH - Lymphatic Metastasis/*genetics MH - Middle Aged MH - Ovarian Neoplasms/*genetics MH - Receptor Protein-Tyrosine Kinases/*genetics MH - Stomach Neoplasms/*genetics/secondary EDAT- 2020/08/01 06:00 MHDA- 2021/10/26 06:00 CRDT- 2020/08/01 06:00 PHST- 2020/03/29 00:00 [received] PHST- 2020/07/16 00:00 [accepted] PHST- 2020/07/16 00:00 [revised] PHST- 2020/08/01 06:00 [pubmed] PHST- 2021/10/26 06:00 [medline] PHST- 2020/08/01 06:00 [entrez] AID - S0893-3952(22)00392-1 [pii] AID - 10.1038/s41379-020-0636-7 [doi] PST - ppublish SO - Mod Pathol. 2021 Jan;34(1):42-50. doi: 10.1038/s41379-020-0636-7. Epub 2020 Jul 30.